Clinical trial
Concurrent Once Daily Versus Twice Daily Radiotherapy for Limited Stage Small…
NCT00433563 · The Christie NHS Foundation Trust, Other · Completed
Key facts
| NCT number | NCT00433563 |
|---|---|
| Title | Concurrent Once Daily Versus Twice Daily Radiotherapy for Limited Stage Small Cell Lung Cancer |
| Official title | A 2-Arm Randomized Controlled Trial of Concurrent Chemo-Radiotherapy Comparing Twice-Daily and Once-Daily Radiotherapy Schedules in Patients With Limited Stage Small Cell Lung Cancer (SCLC) and Good Performance Status [CONVERT] |
| Acronym | CONVERT |
| Lead sponsor | The Christie NHS Foundation Trust, Other |
| Collaborators | Cancer Research UK NCIC Clinical Trials Group European Organisation for Research and Treatment of Cancer - EORTC Spanish Lung Cancer Group Groupe Francais De Pneumo-Cancerologie Intergroupe… |
| Status | Completed |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Radiation |
| Interventions | Once daily radiotherapy, Twice daily radiotherapy |
| Enrollment | 547 |
| Start date | Apr 1, 2008 |
| Primary completion | Feb 1, 2016 |
| Completion | Jan 1, 2019 |
| First posted | Feb 12, 2007 |
| Last update posted | Sep 8, 2022 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: